Rothblatt Martine A's Form 4 filing
United Therapeutics CorpUTHR · filed Oct 27, 2026
- Accession no.
- 0001106578-26-000172
- Filed
- Oct 27, 2026, 4:30 PM ET
- Trade date
- Oct 26, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.59M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $117.76 | +$1,118,720 | 333,943 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −600 | $585.71F3 | −$351,427.32 | 333,343 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −1,492 | $586.54F4 | −$875,124.39 | 331,851 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −2,707 | $587.54F5 | −$1,590,474.3 | 329,144 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −1,241 | $588.47F6 | −$730,285.44 | 327,903 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −1,280 | $589.64F7 | −$754,736.38 | 326,623 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −680 | $590.57F8 | −$401,585.49 | 325,943 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −694 | $591.60F9 | −$410,570.4 | 325,249 | Indirect | |
| Oct 26, 2026 | Common Stock | SSaleDisposed | −806 | $592.92F10 | −$477,890.94 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 157,410 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $585.01 to $585.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $586.035 to $587.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $587.04 to $588.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $588.09 to $589.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $589.10 to $590.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $590.20 to $591.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $591.36 to $592.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $592.46 to $593.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.